A phase II study of liposomal lurtotecan (OSI-211) in...

Gynecologic Oncology 2004 Vol. 93; Iss. 1

A phase II study of liposomal lurtotecan (OSI-211) in patients with topotecan resistant ovarian cancer

Michael V Seiden, Franco Muggia, Allan Astrow, Ursula Matulonis, Susanna Campos, Maria Roche, Julia Sivret, Jason Rusk, Emma Barrett
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
93
Year:
2004
Language:
english
Pages:
4
DOI:
10.1016/j.ygyno.2003.12.037
File:
PDF, 95 KB
english, 2004
Conversion to is in progress
Conversion to is failed